Immuneering Corp Cash Flow Statement

Cash Flow Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -17.04M-33.54M-50.51M-54.81M
Depreciation and Depletion 0.02M0.05M0.25M0.32M0.36M
Share-based Compensation 1.09M1.80M4.06M5.73M6.50M
Deferred Taxes -0.31M
Gains from Investment Securities 1.80M2.86M3.56M-0.00M-0.01M
Non-cash Items 27.62M2.72M
Cash from Operations -14.62M-30.85M-44.10M-48.97M-55.00M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.05M-0.13M0.52M1.02M0.33M
Depreciation & Amortization (CF) 0.02M0.05M0.25M0.32M0.36M
Change in Working Capital
Change in Receivables 0.29M-0.28M-0.23M-0.01M
Change in Account Payables 1.19M-0.13M1.76M-1.11M-0.11M
Change in Accured Expenses 0.49M3.24M0.47M0.72M-0.20M
Other Working Capital Changes 0.07M2.41M0.36M-0.38M-0.30M
Investing Activities
Capital Expenditures 0.05M0.06M0.74M0.34M0.08M
Acquisitions 0.07M
Change in Acquisitions & Divestments 92.68M52.30M31.93M
Cash from Investing Activities -0.05M-75.62M41.83M7.30M26.43M
Financing Activities
Other financing activities 2.12M0.28M0.20M0.04M
Cash from Financing Activities 37.98M144.26M0.02M28.44M5.30M
Additional items
Change in Cash 23.31M37.80M-2.25M-13.23M-23.26M
Free Cash Flow -14.67M-30.91M-44.84M-49.31M-55.08M
Net Cash Flow 23.31M37.80M-2.25M-13.23M-23.26M